Search research articles
Contact Us
Filters
Showing results (31-40 of 109) with videos related to
Page
of 11
Sort By:
American Journal of Clinical and Experimental Urology
|
September 13, 2019
Mri-based cancer lesion analysis with 3d printed patient specific prostate cutting guides
David R Rutkowski, Shane A Wells, Brian Johnson, et al.
SLAS Technology
|
March 17, 2017
Interrogating Bronchoalveolar Lavage Samples via Exclusion-Based Analyte Extraction
Jacob J Tokar, Jay W Warrick, David J Guckenberger, et al.
The Prostate
|
February 28, 2022
Fresh tissue procurement and preparation for multicompartment and multimodal analysis of the prostate tumor microenvironment
Ross A Vitek, Wei Huang, Peter G Geiger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 14, 2021
ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer
Weiyu Chen, Miao Li, Muhsin H Younis, et al.
Journal for Immunotherapy of Cancer
|
March 12, 2022
Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
Douglas G McNeel, Jens C Eickhoff, Ellen Wargowski, et al.
Lab on a Chip
|
October 26, 2013
Paired diagnostic and pharmacodynamic analysis of rare non-small cell lung cancer cells enabled by the VerIFAST platform
Benjamin P Casavant, Lindsay N Strotman, Jacob J Tokar, et al.
Endocrine-Related Cancer
|
July 19, 2021
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer
Mark Daniel, Todd P Knutson, Jamie M Sperger, et al.
Cancers
|
February 15, 2022
Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment
Nan Sethakorn, Erika Heninger, Cristina Sánchez-de-Diego, et al.
Cancer Immunology, Immunotherapy : CII
|
June 8, 2011
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M Lang, Mahazarin R Kaikobad, Marianne Wallace, et al.
Prostate Cancer and Prostatic Diseases
|
September 27, 2024
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)
Anthony V Serritella, Amy Taylor, Michael C Haffner, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 109) with videos related to
Sort By:
Page
of 11
American Journal of Clinical and Experimental Urology
|
September 13, 2019
Mri-based cancer lesion analysis with 3d printed patient specific prostate cutting guides
David R Rutkowski, Shane A Wells, Brian Johnson, et al.
SLAS Technology
|
March 17, 2017
Interrogating Bronchoalveolar Lavage Samples via Exclusion-Based Analyte Extraction
Jacob J Tokar, Jay W Warrick, David J Guckenberger, et al.
The Prostate
|
February 28, 2022
Fresh tissue procurement and preparation for multicompartment and multimodal analysis of the prostate tumor microenvironment
Ross A Vitek, Wei Huang, Peter G Geiger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 14, 2021
ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer
Weiyu Chen, Miao Li, Muhsin H Younis, et al.
Journal for Immunotherapy of Cancer
|
March 12, 2022
Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
Douglas G McNeel, Jens C Eickhoff, Ellen Wargowski, et al.
Lab on a Chip
|
October 26, 2013
Paired diagnostic and pharmacodynamic analysis of rare non-small cell lung cancer cells enabled by the VerIFAST platform
Benjamin P Casavant, Lindsay N Strotman, Jacob J Tokar, et al.
Endocrine-Related Cancer
|
July 19, 2021
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer
Mark Daniel, Todd P Knutson, Jamie M Sperger, et al.
Cancers
|
February 15, 2022
Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment
Nan Sethakorn, Erika Heninger, Cristina Sánchez-de-Diego, et al.
Cancer Immunology, Immunotherapy : CII
|
June 8, 2011
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M Lang, Mahazarin R Kaikobad, Marianne Wallace, et al.
Prostate Cancer and Prostatic Diseases
|
September 27, 2024
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)
Anthony V Serritella, Amy Taylor, Michael C Haffner, et al.
Page
of 11